Immunovant, Inc. (IMVT)
26.02
-0.12
(-0.46%)
USD |
NASDAQ |
Jan 21, 16:00
26.20
+0.18
(+0.69%)
Pre-Market: 08:17
Immunovant Free Cash Flow: -431.34M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Revvity, Inc. | 494.92M |
| Viridian Therapeutics, Inc. | -326.34M |
| Perspective Therapeutics, Inc. | -106.85M |
| Electromed, Inc. | 8.738M |
| InfuSystem Holdings, Inc. | 24.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -102.52M |
| Cash from Financing (Quarterly) | 24.60M |
| Free Cash Flow Per Share (Quarterly) | -0.5904 |
| Free Cash Flow to Equity (Quarterly) | -102.52M |
| Free Cash Flow to Firm (Quarterly) | -102.52M |
| Free Cash Flow Yield | -10.07% |